An interventional study of DOT Pattern and Control Spectacles in Myopia, Myopia Progression, Lag of Accommodation, Hyperopic Retinal Blur, Reduction in Contrast, sponsored by SightGlass Vision, Inc.. Active, not recruiting at 1 site in Canada. Open to participants aged 6 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-05.
Sponsored by SightGlass Vision, Inc. · Not applicable, Interventional, and Treatment
The objective of the study is to measure the difference in the lag of accommodation between DOT spectacle lenses and control spectacles.
984 studies on the registry are indexed under Myopia; 210 are open to participants now.
This study's enrollment of 30 is below the median of 80 across 783 interventional studies indexed under Myopia.
Browse Myopia studies →SightGlass Vision, Inc. is the lead sponsor of 14 studies on the registry; 4 are open to participants now.
Counted across the registry records on this site, refreshed daily.
A person is eligible for inclusion in the study if he/she:
A person will be excluded from the study if he/she:
Spectacle lens or treatment 1
Device: DOT Pattern
Comparator lens or control arm
Device: Control Spectacles
DOT Pattern Spectacle Lens
Control lens
Best vision sphere
1\) Autorefractor spherical equivalent refraction measured at distance and at 40cm with each pair of treatment spectacles
Time frame: 90 minutes
This study is active, not recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
SightGlass Vision, Inc.